Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Silverberg

Showing results (391-400 of 670) with videos related to

Pageof 67
Sort By:
The British Journal of Dermatology|June 20, 2022
Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: EpidemiologyMaria C Schneeweiss, Julien Kirchgesner, Richard Wyss, et al.
Annals of Clinical and Laboratory Science|April 28, 2010
Green tea (Camelia sinensis) suppresses B cell production of IgE without inducing apoptosisEhab Hassanain, Jonathan I Silverberg, Kevin B Norowitz, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 17, 2020
Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis: A phase 2b randomized studyJonathan I Silverberg, Emma Guttman-Yassky, Melinda Gooderham, et al.
American Journal of Clinical Dermatology|October 20, 2022
Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III StudiesLisa Bloudek, Lawrence F Eichenfield, Jonathan I Silverberg, et al.
JAMA Dermatology|May 12, 2021
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical TrialsJonathan I Silverberg, Eric L Simpson, Andreas Wollenberg, et al.
The British Journal of Dermatology|January 18, 2022
The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trialsGil Yosipovitch, Kim Papp, Seth Forman, et al.
Annals of Clinical and Laboratory Science|February 10, 2009
IgE anti-varicella zoster virus and other immune responses before, during, and after shinglesTamar A Smith-Norowitz, Joby Josekutty, Hadar Lev-Tov, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 12, 2018
Health Utility Scores of Atopic Dermatitis in US AdultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 18, 2019
Atopic Dermatitis in US Adults: From Population to Health Care UtilizationJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
International Journal of Biomedical Science : IJBS|May 16, 2013
Long Term Persistence of IgE Anti-Varicella Zoster Virus in Pediatric and Adult Serum Post Chicken Pox Infection and after Vaccination with Varicella Virus VaccineTamar A Smith-Norowitz, Joby Josekutty, Jonathan I Silverberg, et al.
Pageof 67

Showing results (391-400 of 670) with videos related to

Sort By:
Pageof 67
The British Journal of Dermatology|June 20, 2022
Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: EpidemiologyMaria C Schneeweiss, Julien Kirchgesner, Richard Wyss, et al.
Annals of Clinical and Laboratory Science|April 28, 2010
Green tea (Camelia sinensis) suppresses B cell production of IgE without inducing apoptosisEhab Hassanain, Jonathan I Silverberg, Kevin B Norowitz, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 17, 2020
Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis: A phase 2b randomized studyJonathan I Silverberg, Emma Guttman-Yassky, Melinda Gooderham, et al.
American Journal of Clinical Dermatology|October 20, 2022
Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III StudiesLisa Bloudek, Lawrence F Eichenfield, Jonathan I Silverberg, et al.
JAMA Dermatology|May 12, 2021
Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical TrialsJonathan I Silverberg, Eric L Simpson, Andreas Wollenberg, et al.
The British Journal of Dermatology|January 18, 2022
The contribution of itch and skin severity improvements to the Dermatology Life Quality Index in patients with atopic dermatitis in baricitinib phase III trialsGil Yosipovitch, Kim Papp, Seth Forman, et al.
Annals of Clinical and Laboratory Science|February 10, 2009
IgE anti-varicella zoster virus and other immune responses before, during, and after shinglesTamar A Smith-Norowitz, Joby Josekutty, Hadar Lev-Tov, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 12, 2018
Health Utility Scores of Atopic Dermatitis in US AdultsJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 18, 2019
Atopic Dermatitis in US Adults: From Population to Health Care UtilizationJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
International Journal of Biomedical Science : IJBS|May 16, 2013
Long Term Persistence of IgE Anti-Varicella Zoster Virus in Pediatric and Adult Serum Post Chicken Pox Infection and after Vaccination with Varicella Virus VaccineTamar A Smith-Norowitz, Joby Josekutty, Jonathan I Silverberg, et al.
Pageof 67